Wang Chenxi, Zhao Xin, Jiang Jingjing, Jia Mengqi, Shi Wenqing, Wu Zhenghua, Feng Shiyu, Fan Guorong, Lou Yuefen
Department of Pharmacy, Shanghai Fourth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai, China.
Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Front Pharmacol. 2024 Nov 18;15:1481091. doi: 10.3389/fphar.2024.1481091. eCollection 2024.
Rhubarb, containing raw rhubarb (RR) and two processed products (steamed rhubarb, SR; carbonized rhubarb, CR), is commonly used in high-doses for the treatment of peptic ulcer, especially gastric ulcer (GU). However, their active ingredients, therapeutic targets, and potential mechanism remain unclear. Meanwhile, the safety of these active ingredients is also worth studying.
An offline two-dimensional low-pressure liquid chromatography/high-performance liquid chromatography coupled with high resolution mass spectrometry method was applied to identify the chemical constituents of RR, SR, and CR. Then, the plasma and urine samples of rats after oral administration of RR, SR, and CR were studied for metabolite profiling. Based on the analysis of ingredients , the key active constituents, core therapeutic targets and key signaling pathways of RR, SR, and CR against GU were screened network pharmacology and molecular docking. Finally, the efficacy and safety of these key active ingredients were evaluated.
Totally, 183, 120 and 115 compounds were identified or tentatively characterized from RR, SR and CR, respectively. Meanwhile, 190, 182 and 180 components were identified after oral administration of RR, SR and CR. By network pharmacology and molecular docking, torachrysone, hydroxyemodin, 6-methylrhein, rhein and emodin anthrone might be the predominant effective constituents in RR, SR, and CR with AKT1 and EGFR being their key targets during the treatment of GU. Moreover, EGFR/PI3K/AKT signaling pathway might play a crucial role in the therapeutic mechanism of GU. ADMET predictions categorized 5 compounds as drugs with good oral bioavailability, but these components may induce liver injury.
Overall, our results not only clarified the active substances and molecular mechanism for enhancing our understanding about the traditional efficacy, but also pay attention to the clinical safety issues of raw and prepared rhubarbs.
大黄含有生大黄(RR)和两种炮制品(熟大黄,SR;大黄炭,CR),常用于大剂量治疗消化性溃疡,尤其是胃溃疡(GU)。然而,它们的活性成分、治疗靶点及潜在机制仍不清楚。同时,这些活性成分的安全性也值得研究。
采用离线二维低压液相色谱/高效液相色谱联用高分辨率质谱法鉴定RR、SR和CR的化学成分。然后,研究大鼠口服RR、SR和CR后的血浆和尿液样本的代谢物谱。基于成分分析,通过网络药理学和分子对接筛选RR、SR和CR抗GU的关键活性成分、核心治疗靶点和关键信号通路。最后,评估这些关键活性成分的疗效和安全性。
分别从RR、SR和CR中鉴定或初步表征了183、120和115种化合物。同时,口服RR、SR和CR后分别鉴定出190、182和180种成分。通过网络药理学和分子对接,大黄素甲醚、羟基大黄素、6-甲基大黄酸、大黄酸和大黄素蒽酮可能是RR、SR和CR治疗GU的主要有效成分,AKT1和EGFR是其关键靶点。此外,EGFR/PI3K/AKT信号通路可能在GU的治疗机制中起关键作用。ADMET预测将5种化合物归类为具有良好口服生物利用度的药物,但这些成分可能会引起肝损伤。
总体而言,我们的研究结果不仅阐明了活性物质和分子机制,增进了我们对传统疗效的理解,同时也关注生大黄和制大黄的临床安全性问题。